HomeNewsTrendsEntertainmentHow IPRS is upping the royalty game with its Facebook-Instagram tie-up

How IPRS is upping the royalty game with its Facebook-Instagram tie-up

The association, which represents composers, lyricists and music publishers, has been working to ensure that artistes get their due each time their music is used. It is now looking at new revenue streams to increase their royalty payouts

July 31, 2020 / 10:28 IST
Story continues below Advertisement

Music is created once but played many times. From live events to radio, no medium can do without songs. Artistes, however, get paid only once.

The Indian Performing Rights Society (IPRS) is trying to change that by collecting royalties on behalf of artistes each time their songs are played anywhere.

Story continues below Advertisement

It has been around since 1969, but IPRS really started having an impact only from 2017 when it got re-registered as a copyright society and began pushing for implementation of an amendment in The Copyright Act, 1957, to ensure artistes got their due whenever their music was used.

To this end, it is also looking to increase the earnings of artistes by setting up new revenues streams, including through a recent tie-up with Facebook and Instagram.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show